Lang Wu to Cell Line, Tumor
This is a "connection" page, showing publications Lang Wu has written about Cell Line, Tumor.
Connection Strength
0.181
-
Xia WF, Zheng XL, Liu WY, Huang YT, Wen CJ, Zhou HH, Wu QC, Wu LX. Romidepsin exhibits anti-esophageal squamous cell carcinoma activity through the DDIT4-mTORC1 pathway. Cancer Gene Ther. 2024 May; 31(5):778-789.
Score: 0.129
-
Shao YY, Zhang TL, Wu LX, Zou HC, Li S, Huang J, Zhou HH. AKT Axis, miR-21, and RECK Play Pivotal Roles in Dihydroartemisinin Killing Malignant Glioma Cells. Int J Mol Sci. 2017 Feb 10; 18(2).
Score: 0.020
-
Qin CZ, Zhang X, Wu LX, Wen CJ, Hu L, Lv QL, Shen DY, Zhou HH. Advances in molecular signaling mechanisms of ?-phenethyl isothiocyanate antitumor effects. J Agric Food Chem. 2015 Apr 08; 63(13):3311-22.
Score: 0.017
-
Qu Q, Qu J, Zhan M, Wu LX, Zhang YW, Lou XY, Fu LJ, Zhou HH. Different involvement of promoter methylation in the expression of organic cation/carnitine transporter 2 (OCTN2) in cancer cell lines. PLoS One. 2013; 8(10):e76474.
Score: 0.016